Literature DB >> 7667399

Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs.

G Labrecque1, J P Bureau, A E Reinberg.   

Abstract

It is well known that some signs and symptoms of rheumatoid arthritis (RA) vary within a day and between days, and the morning stiffness observed in RA patients has become one of the diagnostic criteria of the disease. Research carried out in the last 10 years confirmed these clinical observations, and circadian, circaseptan or circannual variations were detected in experimental inflammation and in patients with arthritis diseases. The human data showed also that large interindividual differences can be found in the symptoms of RA. The chronopharmacological studies carried out with the non-steroidal anti-inflammatory drugs (NSAID) revealed circadian and circannual variations in the effectiveness, toxicity and pharmacokinetics of NSAID. A review of the available data suggests that peak and trough values found in different arthritic diseases do not occur at the same hour of the day and that the side effects produced by NSAID are more important after the morning than the evening administration. This information should be used by clinicians to determine when to administer drugs to arthritic patients, to optimize the effectiveness of NSAID and/or to reduce the side effects of these drugs. These new data could also be useful to physicians who would like to individualize NSAID use in patients with different arthritic diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667399     DOI: 10.1016/0163-7258(94)00082-e

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

Review 1.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

2.  Circadian rhythms in RA.

Authors:  M Cutolo; B Seriolo; C Craviotto; C Pizzorni; A Sulli
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 3.  Sources of variance in baseline gene expression in the rodent liver.

Authors:  J Christopher Corton; Pierre R Bushel; Jennifer Fostel; Raegan B O'Lone
Journal:  Mutat Res       Date:  2012-01-05       Impact factor: 2.433

4.  Circadian variations in rat liver gene expression: relationships to drug actions.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Debra C DuBois; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2008-06-18       Impact factor: 4.030

Review 5.  Orphan drug development: the increasing role of clinical pharmacology.

Authors:  Mariam A Ahmed; Malek Okour; Richard Brundage; Reena V Kartha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-07-23       Impact factor: 2.745

6.  Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release.

Authors:  M Halsas; P Ervasti; P Veski; H Jürjenson; M Marvola
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

7.  NSAID chronotherapy after impacted third molar extraction: a randomized controlled trial.

Authors:  Zaid Tamimi; Mohammad Abusamak; Haider Al-Waeli; Mohammad Al-Tamimi; Rola Al Habashneh; Mohammad Ghanim; Mohammed Al-Nusair; Qiman Gao; Belinda Nicolau; Faleh Tamimi
Journal:  Oral Maxillofac Surg       Date:  2022-01-22

Review 8.  Pharmacological plasticity-How do you hit a moving target?

Authors:  Michael J Parnham; Gerd Geisslinger
Journal:  Pharmacol Res Perspect       Date:  2019-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.